Pickering IJ, Cheng Q, Rengifo EM, Nehzati S, Dolgova NV, Kroll T, et al
Shedding Light on New Weight Loss Options: A Comparison of Semaglutide, Ozempic, Wegovy, and Mounjaro in Gilbert, AZ Note: This table is for informational purposes only
A recent study from Cornell University finds that households with at least one GLP-1 user reduced grocery spending by 5.5 percent within six months of adoptionequivalent to approximately $416 less per household per year.[77] This decline was especially pronounced among higher-income households and was concentrated in specific product categories, particularly ultra-processed foods such as snacks, sweets, and baked goods.[78] With over 40 percent of American adults living with obesity, even a conservative estimate of 10 percent uptake of GLP-1 therapies within this population would amount to approximately 10 million users
FAK-paxillin pathway activation was strongest at higher local concentrations, supporting injection close to the tendon
This table is designed to be clear and easy for your readers to understand as a quick reference guide on medsdog.com
